The European medicines agency review of belzutifan (Welireg) for the treatment of adult patients with von Hippel–Lindau disease-associated tumors
A Baron, Esther Broekman, Martijn van Gils, Elita Poplavska et autres
nl, lv, pt (code pays fourni par la source)